Intervention not reported
Number of patients with at least one severe/life‐threatening bleeding episode · patients with solid tumours with thrombocytopenia during chemotherapy
1 finding from 1 review
Intervention not reported
Number of treatment cycles with at least one bleeding episode ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of days on which bleeding occurred ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
The amount of bleeding ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life score ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of patients with at least one bleeding episode of any severity · patients with solid tumours without thrombocytopenia before chemotherapy
It is very uncertain whether the intervention changes number of patients with at least one bleeding episode of any severity (very low certainty).
1 finding from 1 review
Intervention not reported
Number of patients with at least one severe/life‐threatening bleeding episode · patients with solid tumours without thrombocytopenia before chemotherapy
It is very uncertain whether the intervention changes number of patients with at least one severe/life‐threatening… (very low certainty).
1 finding from 1 review
Intervention not reported
Number of treatment cycles with at least one bleeding episode ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of days on which bleeding occurred ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
The amount of bleeding ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Quality of life score ‐ not measured · patients with solid tumours without thrombocytopenia before chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Overall survival ‐ not measured · patients with solid tumours with thrombocytopenia during chemotherapy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of patients with at least one bleeding episode of any severity · patients with solid tumours with thrombocytopenia during chemotherapy
It is very uncertain whether the intervention changes number of patients with at least one bleeding episode of any severity (very low certainty).
1 finding from 1 review
Total (all‐cause) mortality · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… showed no clear difference in total (all‐cause) mortality compared with placebo/no antifungal/any other antifungal (moderate certainty).
1 finding from 1 review
Proven invasive fungal infection · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… may leads to lower proven invasive fungal infection compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Superficial fungal infection · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… showed no clear difference in superficial fungal infection compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Fungal colonization · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… may leads to lower fungal colonization compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Treatment cessation due to adverse events · preventing fungal infections in non‐neutropenic critically ill patients
Untargeted antifungal treatment with any antifungal drug (systemic… showed no clear difference in adverse events requiring cessation of study drug(s) compared with placebo/no antifungal/any other antifungal (low certainty).
1 finding from 1 review
Intervention not reported
Overall mortality · treating infections in people with neutropenia or neutrophil dysfunction
It is very uncertain whether the intervention changes overall mortality (very low certainty).
1 finding from 1 review
Intervention not reported
Clinical response to infection · treating infections in people with neutropenia or neutrophil dysfunction
The intervention showed no clear difference in clinical response to infection (low certainty).
1 finding from 1 review